The Clinical Lab Automation Market is projected to reach $3.72 billion by 2030, at a CAGR of 7.8% from 2023 to 2030. Clinical lab automation offers numerous advantages, including the enhancement of diagnostic speed and accuracy, reduction of human errors, cost savings, and increased productivity. Implementing automation in clinical laboratories enables the efficient handling of larger workloads without the need for proportional increases in staffing.
The growth of this market can be attributed to the rising global geriatric population, the increasing prevalence of infectious diseases, and technological advancements in clinical laboratory instruments. However, the high costs of advanced clinical lab automation equipment, coupled with funding and infrastructure limitations in developing countries, restrain the growth of this market.
Furthermore, the increasing demand for automated instruments, technological advancements in molecular diagnostics, and emerging economies are expected to create market growth opportunities. However, factors such as high equipment maintenance and repair costs and concerns over the security and privacy of patient data pose challenges for the market’s growth.
The world is becoming increasingly connected, and infectious diseases are spreading rapidly due to cross-border travel. For instance:
According to the World Health Organization (WHO), in 2021, an estimated 10.6 million people fell ill with tuberculosis (TB), an increase of 4.5% over 2020. In the same year, approximately 1.6 million people died from TB. The burden of Drug-resistant TB (DR-TB) also increased by 3% between 2020 and 2021, with 450,000 cases of Rifampicin-resistant TB (RR-TB) recorded in 2021.
Globally, there were approximately 38.4 million people with HIV in 2021, a significant increase from 33.6 million in 2015. Of these, 36.7 million were adults, and 1.7 million were children (<15 years old). An estimated 1.5 million individuals worldwide acquired HIV in 2021. There were 20.6 million people with HIV (53%) in Eastern and Southern Africa, 5 million (13%) in Western and Central Africa, 6 million (15%) in Asia and the Pacific, and 2.3 million (5%) in Central Europe and North America.
Diagnostic tests are crucial in the medical care of patients who have these diseases. Thus, the increasing prevalence of infectious & chronic diseases is expected to boost the demand for diagnostics, increasing the adoption of automated diagnostic devices and products.
In recent years, laboratories and healthcare institutions have witnessed a major shortage of laboratory workers/professionals. According to the U.S. Bureau of Labor Statistics, the demand for clinical laboratory technicians and technologists is expected to grow by 5% from 2022 to 2032. This increasing demand is attributed to the aging workforce and the decreasing number of accredited training programs. To tackle this challenge, laboratories and hospitals can opt for automated devices such as automated PCR instruments and automated analyzers. The utilization of automated systems has increased since the COVID-19 pandemic. Market players are also focused on the development of automated systems for clinical laboratories. For instance, in October 2020, Kawasaki Heavy Industries, Ltd. (Japan) collaborated with Medicaroid Corporation (Japan) and Sysmex Corporation (Japan) to launch PCR testing services delivered using a mobile, automated system operated by robots to reduce the workload on healthcare professionals and ensure their safety during the pandemic.
Automation can significantly increase the efficiency of laboratories. Clear Labs, Inc. (U.S.), a private genomic testing company, offers a fully automated, next-generation sequencing platform for clinical diagnostics. The company offers Clear Dx and Clear Safety Automated Whole Genome Sequencing (WGS) instruments, which use sequencing, robotics, and cloud-based analytics to detect various types of infections and conditions. Clear Dx was initially used to screen for salmonella and listeria in food products but was redirected to detect pathogens and microorganisms during the COVID-19 pandemic.
Based on product, the clinical lab automation market is segmented into systems and clinical lab automation software. In 2023, the systems segment is expected to account for the largest share of the market. The large market share of this segment is attributed to the benefits of clinical lab automation systems, which facilitate procedures without manual intervention, enhancing laboratory testing capabilities. These systems mitigate repetitive tasks and errors, resulting in increased throughput and efficiency, ultimately improving the quality of test results.
Based on end user the clinical lab automation market is segmented into hospital laboratories, diagnostic laboratories, and other end users. In 2023, the hospital laboratories segment is expected to account for the largest share of the market. Hospital laboratories automate clinical diagnostics to minimize human interventions in laboratory procedures. Automation improves the ordering, testing, and reporting of diagnostic tests in hospitals. Furthermore, the rising healthcare expenditures, the increasing prevalence of chronic diseases, increasing sample loads in hospitals, and improving healthcare infrastructure in developing countries drive the demand for lab automation systems. These factors contribute to the large market share of this segment.
Asia-Pacific is slated to register the highest CAGR in the clinical lab automation market during the forecast period. The growth of this market is primarily driven by the increasing investment by healthcare providers towards infrastructure improvement, the need to manage the growing burden of infectious diseases, the rising demand for clinical testing, supportive government initiatives to improve the accessibility to diagnostic services, and the need to establish more diagnostic laboratories.
The report includes a competitive landscape based on an extensive assessment of the key growth strategies adopted by leading market players over the past few years. The key players profiled in the global clinical lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).
|
Particulars |
Details |
|
Number of Pages |
209 |
|
Format |
|
|
Forecast Period |
2023-2030 |
|
Base Year |
2022 |
|
CAGR |
7.8% |
|
Estimated Market Size (Value) |
$3.72 billion by 2030 |
|
Segments Covered |
By Product
By End User
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Italy, Spain, RoE), Asia-Pacific (China, Japan, India, RoAPAC), Latin America, and the Middle East & Africa. |
|
Key Companies |
Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.) |
This study offers a detailed assessment of the clinical lab automation market, including the market sizes & forecasts for various market segmentations like product and end user. The report also involves the value analysis of various segments of clinical lab automation at the regional and country levels.
The global clinical lab automation market is projected to reach $3.72 billion by 2030, at a CAGR of 7.8% during the forecast period.
Based on product, the clinical lab automation market is segmented into systems and clinical lab automation software. In 2023, the systems segment is expected to account for the largest share of the market.
Based on end user, the clinical lab automation market is segmented into hospital laboratories, diagnostic laboratories, and other end users. In 2023, the hospital laboratories segment is expected to account for the largest share of the market.
The growth of this market can be attributed to the rising global geriatric population, the increasing prevalence of infectious diseases, and technological advancements in clinical laboratory instruments.
Furthermore, the increasing demand for automated instruments, technological advancements in molecular diagnostics, and emerging economies are expected to create market growth opportunities.
The key players operating in the global clinical lab automation market are Thermo Fisher Scientific, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), Revvity, Inc. (Formerly known as PerkinElmer, Inc.) (U.S.), F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), Waters Corporation (U.S.), Tecan Group Ltd. (Switzerland), Siemens Healthineers AG (Germany), Becton, Dickinson, and Company (U.S.), Abbott Laboratories (U.S.), Hudson Robotics, Inc. (U.S.), and Hamilton Company (U.S.).
Emerging economies like China, Brazil, and India are expected to witness significant demand for clinical lab automation systems and offer significant growth opportunities for market players in the coming years.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.2. Factor Analysis
4.3. Regulatory Analysis
4.3.1. Overview
4.3.2. North America
4.3.2.1. U.S.
4.3.2.2. Canada
4.3.3. Europe
4.3.4. Asia-Pacific
4.3.4.1. China
4.3.4.2. Japan
4.3.4.3. India
4.3.5. Latin America
4.3.6. Middle East
4.4. Pricing Analysis
4.5. Industry Trends
4.5.1. Shortage of Skilled Professionals Leading to the Increased Use of Automated Systems
4.5.2. Increasing Applications of Next-Generation Sequencing Technology
4.6. Porter's Five Forces Analysis
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition
5. Clinical Lab Automation Market Assessment–by Product
5.1. Overview
5.2. Systems
5.2.1. Automated Liquid Handling Systems
5.2.2. Automated ELISA Systems
5.2.3. Automated Nucleic Acid Purification Systems
5.2.4. Automated Microplate Readers
5.2.5. Other Systems
5.3. Clinical Lab Automation Software
6. Clinical Lab Automation Market Assessment–by End User
6.1. Overview
6.2. Hospital Laboratories
6.3. Diagnostic Laboratories
6.4. Other End Users
7. Clinical Lab Automation Market Assessment–by Geography
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.3. Europe
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Rest of Europe
7.4. Asia-Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia-Pacific
7.5. Latin America
7.6. Middle East & Africa
8. Competition Analysis
8.1. Overview
8.2. Key Growth Strategies
8.3. Competitive Benchmarking
8.4. Competitive Dashboard
8.4.1. Industry Leaders
8.4.2. Market Differentiators
8.4.3. Vanguards
8.4.4. Emerging Companies
8.5. Market Share Analysis (2022)
8.5.1. Danaher Corporation (U.S.)
8.5.2. Hamilton Company (U.S.)
8.5.3. Abbott Laboratories (U.S.)
9. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, SWOT Analysis)
9.1. Danaher Corporation
9.2. Hamilton Company
9.3. Abbott Laboratories
9.4. F. Hoffmann-La Roche AG
9.5. Thermo Fisher Scientific, Inc.
9.6. Bio-Rad Laboratories, Inc.
9.7. Revvity, Inc. (Formerly Known as PerkinElmer, Inc.)
9.8. Agilent Technologies, Inc.
9.9. Waters Corporation
9.10. Tecan Group Ltd.
9.11. Siemens Healthineers Ag
9.12. Becton, Dickinson, and Company
9.13. Hudson Robotics, Inc.
(Note: SWOT Analysis of Top 5 Companies is Provided)
10. Appendix
10.1. Available Customization
10.2. Related Reports
List of Tables
Table 1 HIV Prevalence, by Region, 2022
Table 2 Global: No. of Deaths Due to Cardiovascular Diseases, 1990–2021
Table 3 Key FDA Regulations for the Clinical Lab Automation Market
Table 4 Classification of Automated Clinical Laboratory Instruments
Table 5 Central Drugs Standard Control Organisation (CDSCO) Medical Device Classification
Table 6 India: Laws Regulating the Life Sciences Industry
Table 7 Clinical Lab Automation Instruments and Systems: Pricing Details
Table 8 Automated NGS Workstations: Pricing Details
Table 9 Global Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 10 Global Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 11 Global Clinical Lab Automation Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Automated Liquid Handling Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 13 Type of Automated ELISA Systems
Table 14 Global Automated ELISA Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Automated Nucleic Acid Purification Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 16 Recent Advancements in Microplate Reader Technology
Table 17 Global Automated Microplate Readers Market, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Other Clinical Lab Automation Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 19 Global Clinical Lab Automation Software Market, by Country/Region, 2021–2030 (USD Million)
Table 20 Global Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 21 Global Clinical Lab Automation Market for Hospital Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 22 Global Clinical Lab Automation Market for Diagnostic Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Clinical Lab Automation Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 24 Global Clinical Lab Automation Market, by Country/Region, 2021–2030 (USD Million)
Table 25 North America: Clinical Lab Automation Market, by Country, 2021–2030 (USD Million)
Table 26 North America: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 27 North America: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 28 North America: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 29 U.S.: Key Macro & Micro Indicators
Table 30 U.S.: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 31 U.S.: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 32 U.S.: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 33 Canada: Key Macro & Micro Indicators
Table 34 Canada: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 35 Canada: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 36 Canada: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 37 Europe: Clinical Lab Automation Market, by Country/Region, 2021–2030 (USD Million)
Table 38 Europe: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 39 Europe: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 40 Europe: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 41 Germany: Key Macro & Micro Indicators
Table 42 Germany: Clinical Lab Automation Market, by Equipment, 2021–2030 (USD Million)
Table 43 Germany: Clinical Lab Automation Market Systems Market, by Type, 2021–2030 (USD Million)
Table 44 Germany: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 45 France: Key Macro & Indicators
Table 46 France: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 47 France: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 48 France: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 49 U.K.: Prevalence of Various Chronic Conditions
Table 50 U.K.: Key Macro & Micro Indicators
Table 51 U.K.: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 52 U.K.: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 53 U.K.: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 54 Italy: Key Macro & Micro Indicators
Table 55 Italy: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 56 Italy: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 57 Italy: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 58 Spain: Key Macro & Micro Indicators
Table 59 Spain: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 60 Spain: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 61 Spain: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 62 Rest of Europe: Percent of Elderly Population (2012 Vs 2021 Vs 2022)
Table 63 Rest of Europe: Cancer Statistics (2020 Vs. 2030)
Table 64 Rest of Europe: Diabetes Statistics (2021 Vs. 2030) (In Thousands)
Table 65 Rest of Europe: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 66 Rest of Europe: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 67 Rest of Europe: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 68 Asia-Pacific: Clinical Lab Automation Market, by Country, 2021–2030 (USD Million)
Table 69 Asia-Pacific: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 70 Asia-Pacific: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 71 Asia-Pacific: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 72 China: Key Macro & Micro Indicators
Table 73 China: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 74 China: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 75 China: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 76 Japan: Key Macro & Micro Indicators
Table 77 Japan: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 78 Japan: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 79 Japan: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 80 India: Key Macro & Micro Indicators
Table 81 India: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 82 India: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 83 India: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 84 Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
Table 85 RoAPAC: Number of People with Diabetes (2021 Vs. 2030 Vs.2045) (In Thousands)
Table 86 Rest of Asia-Pacific: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 87 Rest of Asia-Pacific: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 88 Rest of Asia-Pacific: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 89 Latin America: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 90 Latin America: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 91 Latin America: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 92 Middle East & Africa: Clinical Lab Automation Market, by Product, 2021–2030 (USD Million)
Table 93 Middle East & Africa: Clinical Lab Automation Systems Market, by Type, 2021–2030 (USD Million)
Table 94 Middle East & Africa: Clinical Lab Automation Market, by End User, 2021–2030 (USD Million)
Table 95 Recent Developments, by Company, 2020–2023
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Clinical Lab Automation Market, by Product, 2023 Vs. 2030 (USD Million)
Figure 8 Global Clinical Lab Automation Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 9 Clinical Lab Automation Market Size, by Geography
Figure 10 Global Clinical Lab Automation Market: Impact Analysis of Market Drivers, Restraints, Opportunities, and Challenges (2023–2030)
Figure 11 Population Aged 65 Years or Over, by Region, 2020 Vs. 2030 (In Million)
Figure 12 Global: Estimated Number of New Cancer Cases, 2020–2040 (In Million)
Figure 13 Global Prevalence of Diabetes, 2000–2045 (In Million)
Figure 14 Global: Total Number of Accredited Testing Laboratories, 2016–2020
Figure 15 Incidence of Tuberculosis, by Region, 2021 (In Million)
Figure 16 EU Regulatory Pathway – IVDR 2017/746
Figure 17 China: Medical Devices Classification and Pre-Market Requirements for IVD Devices
Figure 18 Porter's Five Forces Analysis
Figure 19 Global Clinical Lab Automation Market, by Product, 2023 Vs 2030 (USD Million)
Figure 20 Advantages of Using Automated ELISA Systems
Figure 21 Global Clinical Lab Automation Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 22 Global Clinical Lab Automation Market, by Country/Region, 2023 Vs. 2030 (USD Million)
Figure 23 North America: Clinical Lab Automation Market Snapshot
Figure 24 Geriatric Population in Canada (2019–2050)
Figure 25 Estimated Number of New Cancer Cases (2020–2040)
Figure 26 Europe: Clinical Lab Automation Market Snapshot
Figure 27 U.K.: Number of New Sexually Transmitted Infections Diagnosed Per 100,000 Population, 2017–2021
Figure 28 Italy: Percentage of The Population Aged 65 & Above, 2010–2021
Figure 29 Spain: Number of People Living with HIV (2010-2021)
Figure 30 Asia-Pacific: Clinical Lab Automation Market Snapshot
Figure 31 China: Number of New Cancer Cases (2020-2040) (In Million)
Figure 32 Japan: Share of Geriatric Population in Total Population (65 and Over)
Figure 33 Brazil: Number of People with Diabetes (In Thousands)
Figure 34 Key Growth Strategies Adopted by Leading Players 2020-2023
Figure 35 Clinical Lab Automation Market: Competitive Benchmarking by Product Type
Figure 36 Clinical Lab Automation Market: Competitive Benchmarking, by Region
Figure 37 Competitive Dashboard: Clinical Lab Automation Market
Figure 38 Global Clinical Lab Automation Market Share Analysis, by Key Players (2022)
Figure 39 Danaher Corporation: Financial Overview (2022)
Figure 40 Abbott Laboratories: Financial Overview (2022)
Figure 41 F. Hoffmann-La Roche AG: Financial Overview (2022)
Figure 42 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 43 Bio-Rad Laboratories, Inc.: Financial Overview (2022)
Figure 44 PerkinElmer, Inc.: Financial Overview (2022)
Figure 45 Agilent Technologies, Inc.: Financial Overview (2022)
Figure 46 Waters Corporation: Financial Overview (2022)
Figure 47 Tecan Group Ltd.: Financial Overview (2022)
Figure 48 Siemens Healthineers Ag: Financial Overview (2022)
Figure 49 Becton, Dickinson, and Company: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Feb-2024
Published Date: Dec-2023
Published Date: Jun-2022
Published Date: Feb-2022
